HEADER TRANSFERASE 11-NOV-19 6TE2 TITLE CRYSTAL STRUCTURE OF HUMAN PROTEIN KINASE CK2ALPHA' (CSNK2A2 GENE TITLE 2 PRODUCT) IN COMPLEX WITH THE 2-AMINOTHIAZOLE-TYPE INHIBITOR 17 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, ATP-COMPETITIVE INHIBITOR, 2- KEYWDS 2 AMINOTHIAZOLE DERIVATIVE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,D.LINDENBLATT,J.JOSE,V.M.APPLEGATE,A.NICKELSEN REVDAT 2 05-AUG-20 6TE2 1 JRNL REMARK REVDAT 1 08-JUL-20 6TE2 0 JRNL AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.JOSE,K.NIEFIND JRNL TITL STRUCTURAL AND MECHANISTIC BASIS OF THE INHIBITORY POTENCY JRNL TITL 2 OF SELECTED 2-AMINOTHIAZOLE COMPOUNDS ON PROTEIN KINASE CK2. JRNL REF J.MED.CHEM. V. 63 7766 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32589844 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00587 REMARK 2 REMARK 2 RESOLUTION. 0.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 74.0 REMARK 3 NUMBER OF REFLECTIONS : 206560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.128 REMARK 3 R VALUE (WORKING SET) : 0.128 REMARK 3 FREE R VALUE : 0.146 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 0.980 REMARK 3 FREE R VALUE TEST SET COUNT : 2032 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.0700 - 2.2500 0.93 17235 167 0.1364 0.1607 REMARK 3 2 2.2500 - 1.7900 0.90 16578 163 0.1176 0.1250 REMARK 3 3 1.7900 - 1.5600 0.93 17121 174 0.1038 0.1180 REMARK 3 4 1.5600 - 1.4200 0.93 17166 162 0.0983 0.1072 REMARK 3 5 1.4200 - 1.3200 0.84 15499 153 0.1012 0.1154 REMARK 3 6 1.3200 - 1.2400 0.88 16245 182 0.1028 0.1237 REMARK 3 7 1.2400 - 1.1800 0.90 16531 157 0.1088 0.1615 REMARK 3 8 1.1800 - 1.1300 0.90 16560 163 0.1177 0.1462 REMARK 3 9 1.1300 - 1.0800 0.90 16529 167 0.1379 0.1590 REMARK 3 10 1.0800 - 1.0500 0.81 14950 150 0.1754 0.1843 REMARK 3 11 1.0500 - 1.0100 0.80 14800 138 0.2042 0.2244 REMARK 3 12 1.0100 - 0.9800 0.65 11955 120 0.2269 0.2379 REMARK 3 13 0.9800 - 0.9600 0.45 8272 89 0.2420 0.2760 REMARK 3 14 0.9600 - 0.9400 0.24 4484 39 0.2596 0.2202 REMARK 3 15 0.9400 - 0.9100 0.04 713 8 0.2800 0.1866 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.050 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.140 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 8.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.017 2966 REMARK 3 ANGLE : 1.400 4017 REMARK 3 CHIRALITY : 0.114 408 REMARK 3 PLANARITY : 0.011 522 REMARK 3 DIHEDRAL : 16.395 1137 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6TE2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1292105199. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 206560 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.922 REMARK 200 RESOLUTION RANGE LOW (A) : 32.074 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 76.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.03600 REMARK 200 R SYM (I) : 0.03600 REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 0.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 24.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.92700 REMARK 200 R SYM FOR SHELL (I) : 0.92700 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: ARCIMBOLDO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR COMPOSITION: 28 % (W/V) REMARK 280 PEG6000, 0.9 M LICL, 0.1 M, TRIS/HCL, PH 8.5; DROP COMPOSITION REMARK 280 PRIOR TO EQUILIBRATION: 0.01 ML RESERVOIR SOLUTION + 0.02 ML REMARK 280 CK2ALPJA' (MUTANT CYS336SER) /INHIBITOR MB002 MIXTURE (0.180 ML REMARK 280 6 MG/ML CK2ALPHA-'CYS336SER, 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5, REMARK 280 MIXED AND PRE-EQUILIBRATED WITH 0.02 ML 10 MM MB002 IN DIMETHYL REMARK 280 SULFOXIDE); THE INITIAL INHIBITOR MB002 WAS REPLACED BY THE 2- REMARK 280 AMINOTHIAZOLE-TYPE INHIBITOR 17 BY EXTENSIVE CRYSTAL SOAKING., REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 GLN A 334 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A 116 CE2 TYR A 116 CD2 -0.090 REMARK 500 GLU A 140 CD GLU A 140 OE1 -0.068 REMARK 500 TYR A 147 CE2 TYR A 147 CD2 0.092 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 20 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 20 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 65 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 157 42.21 -149.89 REMARK 500 ASP A 176 79.66 56.40 REMARK 500 ALA A 186 -1.75 76.28 REMARK 500 ALA A 194 158.38 64.14 REMARK 500 ALA A 194 163.10 64.14 REMARK 500 MET A 209 52.63 -92.55 REMARK 500 HIS A 235 73.40 -107.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 935 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A 936 DISTANCE = 6.14 ANGSTROMS REMARK 525 HOH A 937 DISTANCE = 6.41 ANGSTROMS REMARK 525 HOH A 938 DISTANCE = 6.55 ANGSTROMS REMARK 525 HOH A 939 DISTANCE = 7.40 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N4N A 401 DBREF 6TE2 A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 6TE2 MET A -13 UNP P19784 INITIATING METHIONINE SEQADV 6TE2 GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 6TE2 SER A -11 UNP P19784 EXPRESSION TAG SEQADV 6TE2 SER A -10 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 6TE2 HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 6TE2 SER A -3 UNP P19784 EXPRESSION TAG SEQADV 6TE2 GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 6TE2 ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 6TE2 PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 6TE2 SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION SEQRES 1 A 364 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 364 PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG VAL SEQRES 3 A 364 TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR TRP SEQRES 4 A 364 ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN ASP SEQRES 5 A 364 ASP TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SEQRES 6 A 364 SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU SEQRES 7 A 364 ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS SEQRES 8 A 364 LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU ARG SEQRES 9 A 364 GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL LYS SEQRES 10 A 364 ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU TYR SEQRES 11 A 364 ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE LEU SEQRES 12 A 364 THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU LEU SEQRES 13 A 364 LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET HIS SEQRES 14 A 364 ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLN SEQRES 15 A 364 GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU SEQRES 16 A 364 PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL ALA SEQRES 17 A 364 SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR SEQRES 18 A 364 GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY SEQRES 19 A 364 CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO PHE SEQRES 20 A 364 PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG ILE SEQRES 21 A 364 ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR LEU SEQRES 22 A 364 LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN ASP SEQRES 23 A 364 ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN PHE SEQRES 24 A 364 ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU ALA SEQRES 25 A 364 LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SEQRES 26 A 364 GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO TYR SEQRES 27 A 364 PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER ALA SEQRES 28 A 364 ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA ARG HET N4N A 401 31 HETNAM N4N 3-[(4-PYRIDIN-2-YL-1,3-THIAZOL-2-YL)AMINO]BENZOIC ACID FORMUL 2 N4N C15 H11 N3 O2 S FORMUL 3 HOH *439(H2 O) HELIX 1 AA1 SER A 21 ASP A 26 1 6 HELIX 2 AA2 TYR A 27 HIS A 30 5 4 HELIX 3 AA3 LYS A 75 LEU A 89 1 15 HELIX 4 AA4 ASP A 121 TYR A 126 1 6 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 ASP A 176 ALA A 180 5 5 HELIX 8 AA8 SER A 195 LYS A 199 5 5 HELIX 9 AA9 GLY A 200 VAL A 205 1 6 HELIX 10 AB1 TYR A 212 ARG A 229 1 18 HELIX 11 AB2 ASP A 238 GLY A 251 1 14 HELIX 12 AB3 GLY A 251 HIS A 263 1 13 HELIX 13 AB4 ASP A 267 ILE A 273 5 7 HELIX 14 AB5 ARG A 281 ILE A 286 5 6 HELIX 15 AB6 ASN A 290 VAL A 294 5 5 HELIX 16 AB7 SER A 295 LEU A 306 1 12 HELIX 17 AB8 THR A 315 GLU A 321 1 7 HELIX 18 AB9 HIS A 322 TYR A 324 5 3 HELIX 19 AC1 PHE A 325 GLN A 332 1 8 SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ASP A 100 SHEET 4 AA1 6 ARG A 65 LEU A 71 -1 N VAL A 67 O PHE A 114 SHEET 5 AA1 6 SER A 52 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 ARG A 48 -1 N LEU A 46 O VAL A 54 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166 CISPEP 1 GLU A 231 PRO A 232 0 -13.80 SITE 1 AC1 14 LEU A 46 LYS A 69 PHE A 114 TYR A 116 SITE 2 AC1 14 ILE A 117 ASN A 119 MET A 164 ILE A 175 SITE 3 AC1 14 ASP A 176 HOH A 544 HOH A 594 HOH A 611 SITE 4 AC1 14 HOH A 627 HOH A 716 CRYST1 46.339 47.493 50.357 66.81 89.93 88.97 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021580 -0.000386 0.000135 0.00000 SCALE2 0.000000 0.021059 -0.009022 0.00000 SCALE3 0.000000 0.000000 0.021604 0.00000